Browsing Technical documents and research evidence on COVID-19 by Title
Now showing items 424-443 of 1749
-
Covid2019 / SARSCoV2 coronavirus antivirals
(2020-04-20)Includes: Interferons, Nucleoside analogs, Protease inhibitors, Furin Convertase Cleavage inhibitors, Reverse transcriptase inhibitors, RNA Polymerase/Synthesis Inhibitors, Neuraminidase inhibitors, Angiotensin II receptor ... -
COVID‐19 and gastrointestinal endoscopies: current insights and emergent strategies
(2020-04-13)A new coronavirus emerged in December 2019 in Wuhan city of China, named as the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), and disease was called as coronavirus disease‐2019 (COVID‐19). The infection due ... -
COVID‐19 in a Designated Infectious Diseases Hospital Outside Hubei Province, China
(2020-04-02)[Abstract]. Background: The clinical characteristics of novel coronavirus disease (COVID‐2019) patients outside the epicenter of Hubei province are less understood. Methods: We analyzed the epidemiological and clinical ... -
COVID‐19 in Seattle—Early lessons learned
(2020-03-25)The coronavirus disease 2019 (COVID‐19) pandemic has rapidly evolved and now dominates the attention and full efforts of the emergency medicine community, both domestic and abroad. Seattle is the site of the initial diagnosed ... -
The covid‐19 pandemic, personal protective equipment, and respirator: a narrative review
(2020-06-08)The coronavirus disease 2019 (COVID‐19) pandemic has touched almost every continent. Personal protective equipment (PPE) is the final line of protection of healthcare workers (HCW). There is variation as well as controversy ... -
COVID‐19 treatment by repurposing drugs until the vaccine is in sight
(2020-03-29)Corona virus disease (COVID-19) has created pandemic in the world as declared by WHO on March 12, 2020. It is a viral disease caused by SARS-CoV 2 virus and has affected large populations in over 120 countries. There is ... -
Creating a Palliative Care Inpatient Response Plan for COVID19 – The UW Medicine Experience
(2020-03-24)[Abstract]. Introduction: The COVID-19 pandemic is stressing healthcare systems throughout the world. Significant numbers of patients are being admitted to the hospital with severe illness, often in the setting of advanced ... -
Critical preparedness, readiness and response actions for COVID-19 - 7 March 2020
All countries should increase their level of preparedness, alert and response to identify, manage and care for new cases of COVID-19. Countries should prepare to respond to different public health scenarios, recognizing ... -
Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids
(2014)Cross-infection enhancement of seven African flaviviruses by subneutralising concentrations of antibody in immune ascitic fluids was investigated in P388D1 cell culture. Infection by all the seven flaviviruses tested was ... -
CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city
(2020-04-11)[Abstract]. Objectives: To characterize the chest computed tomography (CT) findings of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) according to clinical severity. We compared the CT features of common cases ... -
CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19)
(2020-03-25)Objectives: To explore the relationship between the imaging manifestations and clinical classification of COVID-19. Methods: We conducted a retrospective single-center study on patients with COVID-19 from Jan. 18, 2020 to ... -
Curbing the AI-induced enthusiasm in diagnosing COVID-19 on chest X-Rays: the present and the near-future
(2020-05-01)In the current context of COVID-19 pandemic, a rapid and accessible screening tool based on image processing of chest X-rays (CXRs) using machine learning (ML) approaches would be much needed. Initially, we intended to ... -
Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis
(2020-12-15)Background: Interleukin-6 (IL-6) is known to be detrimental in coronavirus disease 2019 (COVID-19) because of its involvement in driving cytokine storm. This systematic review and meta-analysis aimed to assess the safety ... -
Current evidence of SARS-CoV-2 vertical transmission: an integrative review
(2020-09-21)OBJECTIVE: To review the current scientific evidence of vertical transmission related to coronavirus disease 2019 (COVID-19). METHODS: An integrative review was performed by two independent researchers, based on the ... -
Current tobacco smoking and risk from COVID-19: results from a population symptom app in over 2.4 million people
(2020-05-21)Background: The association between current tobacco smoking, the risk of developing COVID-19 and the severity of illness is an important information gap. Methods: UK users of the COVID Symptom Study app provided baseline ... -
Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
(2020-07-08)Background: COVID‐19 had a great impact on medical approaches among dermatologist. Objective: This systematic review focuses on all skin problems related to COVID‐19, including primary and secondary COVID‐related cutaneous ... -
Cutaneous manifestations of the Zika virus
(2016-06)The Zika virus outbreak in Africa, Asia, the Americas, and the Pacific has drawn attention to the virus in the media and medical community. As of February 10, 2016, 52 travel-related cases of Zika virus have been reported ... -
Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase
(2016)Zika virus is an emerging mosquito-borne flavivirus currently causing large epidemics in the Pacific Ocean region and Brazil. Clinically, Zika fever resembles dengue fever, but is less severe. Whereas the clinical syndrome ...